A detailed history of Invesco Ltd. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Invesco Ltd. holds 75,467 shares of KOD stock, worth $200,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,467
Previous 705,317 89.3%
Holding current value
$200,742
Previous $3.71 Million 95.23%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.29 - $4.48 $1.44 Million - $2.82 Million
-629,850 Reduced 89.3%
75,467 $177,000
Q1 2024

May 14, 2024

BUY
$3.01 - $7.45 $1.88 Million - $4.66 Million
626,122 Added 790.61%
705,317 $3.71 Million
Q4 2023

Feb 12, 2024

BUY
$1.4 - $3.24 $672 - $1,555
480 Added 0.61%
79,195 $240,000
Q3 2023

Nov 13, 2023

BUY
$1.8 - $7.49 $17,717 - $73,724
9,843 Added 14.29%
78,715 $141,000
Q2 2023

Aug 11, 2023

BUY
$4.3 - $9.48 $14,667 - $32,336
3,411 Added 5.21%
68,872 $475,000
Q1 2023

May 12, 2023

BUY
$4.81 - $8.88 $199,667 - $368,617
41,511 Added 173.32%
65,461 $405,000
Q4 2022

Feb 13, 2023

SELL
$6.52 - $8.05 $665 - $821
-102 Reduced 0.42%
23,950 $171,000
Q3 2022

Nov 14, 2022

SELL
$7.57 - $12.5 $5,980 - $9,875
-790 Reduced 3.18%
24,052 $186,000
Q2 2022

Aug 15, 2022

SELL
$5.04 - $9.48 $1,421 - $2,673
-282 Reduced 1.12%
24,842 $190,000
Q1 2022

May 16, 2022

SELL
$7.09 - $89.45 $3.81 Million - $48 Million
-537,033 Reduced 95.53%
25,124 $194,000
Q4 2021

Feb 14, 2022

SELL
$80.85 - $128.49 $488,091 - $775,694
-6,037 Reduced 1.06%
562,157 $47.7 Million
Q3 2021

Nov 15, 2021

BUY
$81.97 - $106.94 $15.1 Million - $19.7 Million
184,682 Added 48.16%
568,194 $54.5 Million
Q2 2021

Aug 17, 2021

BUY
$77.2 - $126.54 $232,680 - $381,391
3,014 Added 0.79%
383,512 $35.7 Million
Q1 2021

May 17, 2021

SELL
$110.45 - $164.47 $6.15 Million - $9.15 Million
-55,639 Reduced 12.76%
380,498 $43.1 Million
Q4 2020

Feb 16, 2021

BUY
$60.78 - $154.03 $26.5 Million - $67.2 Million
436,137 New
436,137 $64.1 Million
Q3 2020

Nov 16, 2020

SELL
$45.05 - $59.27 $1.63 Million - $2.15 Million
-36,281 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$42.74 - $66.25 $119,714 - $185,566
-2,801 Reduced 7.17%
36,281 $1.96 Million
Q1 2020

May 15, 2020

SELL
$38.18 - $73.95 $2.31 Million - $4.47 Million
-60,437 Reduced 60.73%
39,082 $1.87 Million
Q4 2019

Feb 14, 2020

BUY
$13.9 - $76.65 $615,533 - $3.39 Million
44,283 Added 80.17%
99,519 $7.16 Million
Q3 2019

Nov 14, 2019

BUY
$10.24 - $17.57 $565,616 - $970,496
55,236 New
55,236 $794,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $138M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.